In the past few years I have found some examples of papers showing photos of mice or rats with very large tumors. Some of these tumors appear to go far beyond what animal ethics guidelines consider to be acceptable.
This post contains images that might be disturbing to some viewers. So, please proceed with caution.
Continue reading “Animal ethics misconduct: mice with very large tumors”
Recently a paper published in Nucleic Acid Therapeutics, a Mary Liebert publication not to be confused with the more glamorous Nucleic Acid Research journal, was brought to my attention. It described the potential use of small RNAs as a therapeutic against SARS-CoV-2.
Alas, it is most memorable because of the alarmingly short time-to-acceptance, lack of references, and the omission of several conflicts of interest.
Continue reading “COVID-19, small RNAs, and conflicts of interest”
There has been a lot of excitement – and even a presidential tweet about a recent paper from the lab of Didier Raoult, an infectious disease specialist in Marseille, France. But although this study might offer a glimmer of hope, there are some serious problems with the paper too.
Continue reading “Thoughts on the Gautret et al. paper about Hydroxychloroquine and Azithromycin treatment of COVID-19 infections”
In 2016, with coauthors Arturo Casadevall and Ferric Fang, I published a study on 20,000 biomedical papers with photographic images, in which we found an average of 4% to contain inappropriately duplicated images.
Not surprisingly, we found that percentage to vary per journal. Some of the 40 journals we investigated had much higher percentages of image duplicates than others.
Continue reading “A study on Oncotarget papers”
In the past months I have been going through my spreadsheet with over 2,000 papers with image or other problems. Many of these papers were reported by me in 2014 and 2015 to the editors of the journals in which they were published. Now, around 5 years later, it is time to see what happened with my reports.
In this post, I want to show you an example of a paper that I reported in 2014, and that was corrected about a year later.
In my opinion, the Editors of the journal made a huge mistake here. This should have been a retraction.
Continue reading “Mega-corrections and weak editors”
Note: this post is not an allegation of misconduct. I do not have any strong feelings about low- or high-carb diets.
This post tells the tale of three paper. Paper #1 was retracted, republished as paper #2, and republished a second time as paper #3. Let’s take a look at what happened. Based on an original Twitter thread on Twitter and on ThreadReaderApp.
Continue reading “Three diets, three papers, one retraction, and lots of concerns”